Found in Feb. 22 2001, Liaoning oxiranphex Inc. is a national high-tech enterprise with 50 million RMB registered capital. Subsidiary of oxiranchem group,Intergration of R&D, manufacture and sale with the strict implementation of the corresponding GMP, The establishment of quality, environment, occupation health is a whole body QHSE management system. It is the domestic first-class medical polyethylene glycol and its derivative. Company meet the requirements of ChP2015 with full inspection ability, instruments and equipment. Varieties of product exported abroad.
In 2015, according to the international cGMP and American FDA standard, Oxiranphex moves to the new manufacturing site, which invested 100 million RMB to finish the construction of “annual productivity of 10,000 tons Pharmaceutical Excipients project”.
Oxiranchem group Overview
Oxiranchem group was formed in Liaoyang, China in 2000. Based on the Liaoning oxiranchem lnc., as the investment main body. Was the state Hi-Tech company and state innovative enterprise. In addition,oxiranchem had state R&D laboratory which identified and integrated new technology into Oxiranchem’s existing nationwide markets.
The company listed in china in 2010
Company insisted on development strategy of “Based on ethylene oxide to create value”, the market exploitation principle of “Bigger trend, Bigger market, Smaller competition”,Oxiranchem Group has become the fastest growing in the deep processing of domestic ethylene oxide industry, one of the largest leading enterprise, its product technology reached the international leading level.